Validations: Biologics, ATMP & Viral Safety Validation
Common Spiking Study Errors—and How to Avoid Them Viral clearance validation is a critical aspect of ensuring the safety and efficacy of biologics and advanced therapy medicinal products (ATMPs). Among various methods utilized to assess viral clearance, spiking studies play a vital role. However, inaccuracies and oversights in the execution of these studies can compromise the reliability of validation results….
Templates: Spiking Protocols and Reports Templates: Spiking Protocols and Reports Viral clearance validation is a critical component of the biologics and advanced therapy medicinal products (ATMP) development process. It not only ensures the safety and efficacy of therapeutic products but also aligns with regulatory expectations from agencies such as the US FDA, EMA, and MHRA. This detailed guide focuses on…
Retrovirus Safety: MVM and MuLV Considerations Introduction to Viral Clearance Validation In the biopharmaceutical industry, ensuring the safety and efficacy of products is paramount. This is particularly true when these products are developed from biological sources or involve advanced therapy medicinal products (ATMPs). One critical area of concern is viral clearance validation. The two retroviruses, namely murine leukemia virus (MuLV)…
Scaling Viral Clearance Data Across Sites Scaling Viral Clearance Data Across Sites In the complex world of pharmaceutical development, especially in the biologics and Advanced Therapy Medicinal Products (ATMP) sectors, ensuring viral safety is paramount. The validation of viral clearance processes constitutes a critical component of compliance with regulatory requirements imposed by agencies such as the FDA, the European Medicines…
Linking Clearance to Patient Risk and Specifications In the realm of biologics and advanced therapy medicinal products (ATMP), ensuring product safety and efficacy is paramount. Viral clearance validation serves a critical purpose in aligning the manufacturing process with regulatory requirements while safeguarding patient health. This tutorial offers a comprehensive guide for pharmaceutical professionals to understand the essentials of viral clearance…
Dealing with Inhibitors in Complex Matrices The biopharmaceutical industry frequently encounters challenges in achieving robust viral clearance validation when working with complex matrices. These matrices, often intrinsic to advanced therapy medicinal products (ATMPs) and biologics, can introduce inhibitors that complicate both the viral clearance validation processes and the interpretation of results. This guide provides a systematic approach to overcoming these…
Outsourced Spiking Labs: Qualification and Oversight Outsourced Spiking Labs: Qualification and Oversight In the evolving landscape of biopharmaceuticals, the need for efficient viral clearance validation, especially in Advanced Therapy Medicinal Products (ATMPs), has become paramount. Outsourcing spiking studies to specialized laboratories can enhance operational efficiency, but it necessitates a comprehensive understanding of qualification and oversight methodologies. This guide offers a…
Interpretation Packages: Tables, Graphs, and Narratives in Viral Clearance Validation In the evolving landscape of biopharmaceuticals, understanding the intricacies of viral clearance validation is essential. This guide aims to provide a comprehensive overview of the processes involved in establishing effective viral clearance through spiking studies, particularly in the context of closed and single-use systems. It is tailored for professionals in…
Viral Surrogates & Model Selection: Defensibility in Filings Viral Surrogates & Model Selection: Defensibility in Filings In the realm of biopharmaceutical development, particularly when dealing with advanced therapy medicinal products (ATMPs) and biologics, ensuring viral safety is of paramount importance. The regulatory guidelines from authorities such as the US FDA, EU EMA, and UK MHRA emphasize the necessity of rigorous…
Inactivation vs Removal: Combining for Robust LRVs This guide aims to provide a comprehensive understanding of inactivation and removal strategies for viral clearance validation, especially in the context of advanced therapy medicinal products (ATMPs). Both inactivation and removal are essential components of a robust viral clearance strategy, and their effective combination can significantly enhance the robustness of large reductions in…